Active	Status	Sponsor type	Region	Phase	Filter
2 Active 6 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Burch, Ronald M
NCT06547489: GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive Disorder	Recruiting	2	164	US	Zelquistinel, GATE-251	Gate Neurosciences, Inc, Worldwide Clinical Trials	Major Depressive Disorder	08/26	12/26
NCT05597241: Multiple Ascending Dose and Electroencephalography Trial of GATE-202 in Healthy Volunteers	Completed	1	40	US	apimostinel, GATE-202, Placebo	Gate Neurosciences, Inc	Major Depressive Disorder	04/23	04/23